tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
Lumos Pharma's activity chart (see below) currently has 46 price targets and 54 ratings on display.
Analysts average stock forecasts to be materialized ratio is 37.03% with an average time for these price targets to be met of 165.8 days.
Most recent stock forecast was given by from HC WAINWRIGHT on 08-Nov-2024.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 08-Nov-2024
$4.25
$-0.09 (-2.07%)
$4.25
1 years 10 months 27 days ago
(08-Nov-2024)
2/7 (28.57%)
$-0.11 (-2.52%)
93
Buy Since 13-Apr-2021
$4.25
$-0.09 (-2.07%)
$34
1 years 11 months 12 days ago
(23-Oct-2024)
0/2 (0%)
$-0.11 (-2.52%)
Buy Since 20-Jul-2022
$18
2 years 2 months 3 days ago
(02-Aug-2024)
0/3 (0%)
$15.76 (703.57%)
Buy Since 03-Dec-2020
$10
$5.66 (130.41%)
$10
3 years 1 months 13 days ago
(22-Aug-2023)
1/3 (33.33%)
$7.03 (236.70%)
28
Buy Since 16-Apr-2020
$7
$2.66 (61.29%)
$7
3 years 9 months 27 days ago
(08-Dec-2022)
2/4 (50%)
$2.8 (66.67%)
79
What is LUMO (Lumos Pharma) average time for price targets to be met?
Which analyst most recently updated their price target on LUMO (Lumos Pharma)?
Which analyst has the most public recommendations on LUMO (Lumos Pharma)?
Which analyst is the currently most bullish on LUMO (Lumos Pharma)?
Which analyst is the currently most reserved on LUMO (Lumos Pharma)?
